The Long Road Back

The Long Road Back

Yesterday Medtronic CEO Geoff Martha was speaking at the Goldman Sachs global healthcare conference and made some interesting comments on the company’s diabetes unit. While we will get to those comments in a moment it’s important to look backward before we can look forward. It’s critical to understand how things got this way. We’ve covered this before and there is plenty of material in the archives, so we won’t go into all the gory details just the highlights.

Phase One MiniMed vs Disetronic

It was generally acknowledge back in the day that Disetronic . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.